{"id":2325,"date":"2010-04-13T18:20:00","date_gmt":"2010-04-13T22:20:00","guid":{"rendered":"https:\/\/www.med.unc.edu\/derm\/patient-care\/specialties\/high-risk-non-melanoma-skin-cancer\/"},"modified":"2018-07-05T08:20:09","modified_gmt":"2018-07-05T12:20:09","slug":"high-risk-non-melanoma-skin-cancer","status":"publish","type":"page","link":"https:\/\/www.med.unc.edu\/derm\/patient-care\/clinical-services\/high-risk-non-melanoma-skin-cancer\/","title":{"rendered":"High Risk Non-Melanoma Skin Cancer"},"content":{"rendered":"

Over the past several years we have worked to establish a clinic where we use numerous non-surgical techniques to help treat non-melanoma skin cancers. We have focused on these techniques because certain patients may not be able or willing to tolerate surgical intervention. For example, solid organ transplant patients can see their risk of Non-Melanoma Skin Cancer (NMSC) increase by as much as 200-fold. It is often necessary to treat numerous concerning lesions at a time in order to contain risk of spreading. We have used numerous techniques including photodynamic therapy, laser therapy, intralesional therapy and systemic medications to treat many types of non-melanoma skin cancer. When necessary, we also use surgical techniques like curettage and standard excision.<\/p>\n

Your Physicians:<\/b><\/p>\n

\n \n
\n
\n \t\t\n
\n \"Puneet\n \"\"\n <\/div>\t\t\t\t\t\t\t\t\t\n <\/div>\n
\n

\n Puneet Jolly, MD, PhD <\/a>\n <\/h2> \n \n

Adult Dermatology
\nDermatologic Surgery<\/p>\n

Special Interests:
\n<\/span><\/b>High Risk Non-Melanoma Skin Cancer (Transplant Dermatology)<\/span><\/p>\n <\/div>\n <\/article>\n\n \n